New: 2026 Peptide Research Digest is live. Read the report
Research-backed content PubMed cited sources Medically reviewed by experts Quarterly content updates Research-backed content PubMed cited sources Medically reviewed by experts Quarterly content updates Research-backed content PubMed cited sources Medically reviewed by experts Quarterly content updates Research-backed content PubMed cited sources Medically reviewed by experts Quarterly content updates Research-backed content PubMed cited sources Medically reviewed by experts Quarterly content updates Research-backed content PubMed cited sources Medically reviewed by experts Quarterly content updates Research-backed content PubMed cited sources Medically reviewed by experts Quarterly content updates Research-backed content PubMed cited sources Medically reviewed by experts Quarterly content updates

CJC-1295

Growth Hormone

Modified GRF 1-29

Calculate Reconstitution Read Full Data Guide

Overview Profile

A synthetic GHRH analog that increases plasma growth hormone and IGF-1 levels without significantly affecting prolactin.

Primary Target Benefits

muscle growthfat lossanti-aging

Research Notice: This profile is informational. Peptides are widely sold as research chemicals and many are not FDA-approved for human consumption. Always consult local regulations and a medical provider before proceeding.

Quick Research Facts

Standard Dose Observation

100-300 mcg

Typical Available Vial Sizes

2mg5mg

Development / Research Status

Preclinical

More in Growth Hormone

Ipamorelin

Selective GHRP

View Profile

CJC-1295 / Ipamorelin

GHRH & GHRP Blend

View Profile